Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cataract-ataxia-deafness syndrome is characterized by mild intellectual deficit, congenital cataract, progressive sensorineural deafness and ataxia. It has been described in two sisters. The inheritance is likely to be autosomal recessive.
Features include: Mild intellectual disability, Short stature, Polyneuropathy, and Developmental cataract and 4 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 3 | Mild intellectual disability, Polyneuropathy, Ataxia |
Growth and development |
Biomarker and diagnostic research for cataract-ataxia-deafness syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for cataract-ataxia-deafness syndrome.
208 publications have been identified in PubMed for cataract-ataxia-deafness syndrome. Research spans Review / Meta-Analysis (59%), Basic Science / Preclinical (13%), and Case Report / Case Series (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 122 | 59% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 9:41 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1 |
Short stature |
Eyes | 1 | Developmental cataract |
Ears | 1 | Adult onset sensorineural hearing impairment |
Age of onset: later in life.
Laboratory research
26 |
13% |
Patient case studies | 23 | 11% |
Disease patterns and progression | 23 | 11% |
Other research | 5 | 2% |
Testing and diagnosis research | 5 | 2% |
New treatment approaches | 2 | 1% |
Clinical study results | 1 | 0% |
Morin G (2026). [PMID: 41173190](https://pubmed.ncbi.nlm.nih.gov/41173190/). *Kidney Int*. [Review / Meta-Analysis]
Fujiwara K (2026). [PMID: 41418585](https://pubmed.ncbi.nlm.nih.gov/41418585/). *Auris Nasus Larynx*. [Case Report / Case Series]
Graafen L (2026). [PMID: 41831046](https://pubmed.ncbi.nlm.nih.gov/41831046/). *J Clin Immunol*. [Diagnostic / Biomarker]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Beuriat PA (2026). [PMID: 42115454](https://pubmed.ncbi.nlm.nih.gov/42115454/). *Adv Tech Stand Neurosurg*. [Review / Meta-Analysis]
Sebode M (2026). [PMID: 41432137](https://pubmed.ncbi.nlm.nih.gov/41432137/). *Curr Opin Gastroenterol*. [Review / Meta-Analysis]
Buel KL (2026). [PMID: 41569909](https://pubmed.ncbi.nlm.nih.gov/41569909/). *FP Essent*. [Review / Meta-Analysis]
Uhlenbusch N (2026). [PMID: 41623132](https://pubmed.ncbi.nlm.nih.gov/41623132/). *Liver Int*. [Epidemiology / Natural History]
Anandan S (2026). [PMID: 41818118](https://pubmed.ncbi.nlm.nih.gov/41818118/). *J Assoc Physicians India*. [Case Report / Case Series]
Buckner J (2026). [PMID: 41250525](https://pubmed.ncbi.nlm.nih.gov/41250525/). *Subst Use Misuse*. [Epidemiology / Natural History]